Skip to main content

Pharmacokinetics in Healthy Subjects

1
Pipeline Programs
1
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Allecra Therapeutics
Allecra TherapeuticsFrance - Saint Louis
1 program
1
cefepimePhase 15 trials
Active Trials
NCT03687255Completed1,043Est. Feb 2020
NCT03680612Completed45Est. Feb 2018
NCT03680352Completed30Est. Dec 2018
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime
Allecra Therapeuticscefepime

Clinical Trials (5)

Total enrollment: 1,193 patients across 5 trials

NCT03687255Allecra Therapeuticscefepime

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

Start: Sep 2018Est. completion: Feb 20201,043 patients
Phase 3Completed
NCT03680612Allecra Therapeuticscefepime

Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI

Start: Sep 2017Est. completion: Feb 201845 patients
Phase 2Completed
NCT03680352Allecra Therapeuticscefepime

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

Start: Sep 2017Est. completion: Dec 201830 patients
Phase 1Completed
NCT03680378Allecra Therapeuticscefepime

Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)

Start: Jul 2017Est. completion: Apr 201919 patients
Phase 1Completed
NCT03685084Allecra Therapeuticscefepime

Investigation of AAI101 Safety, Tolerability & PK in Healthy Volunteers

Start: Oct 2013Est. completion: Jan 201456 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.